News for PDS Biotechnology Corporation (PDSB)

Published at

Feb 24, 2025 2:00 PM

by gurufocus.com

positive

positive

PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research

Data confirms Versamune® HPV has potential as a broadly effective treatment of HPV16-associated cancers ”“ Initiation of Phase 3 trial in HPV16-positive HNSCC

PDSB

Read more →
Published at

Dec 6, 2024 2:10 PM

by manilatimes.net

positive

positive

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

**media[485339]**

PDSB

Read more →
Published at

Dec 6, 2024 2:00 PM

by benzinga.com

positive

positive

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PDS Biotechnology (NASDAQ:PDSB)

PRINCETON, N.J., Dec. 06, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (

PDSB

Read more →
Published at

Dec 3, 2024 3:00 PM

by gurufocus.com

positive

positive

PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET

Discussion topics to include pathology and prevalence of HPV16-positive head and neck cancer, VERSATILE-003 Phase 3 clinical trial design and initiation PRINC

PDSB

Read more →
Published at

Nov 20, 2024 3:35 PM

by zacks.com

neutral

neutral

Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for PDS Biotechnology (PDSB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PDSB

Read more →
Published at

Nov 14, 2024 5:18 PM

by seekingalpha.com

neutral

neutral

PDS Biotechnology Corporation (PDSB) Q3 2024 Earnings Call Transcript

PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsTom Johnson - LifeSci...

PDSB

Read more →
Published at

Nov 14, 2024 2:19 PM

by manilatimes.net

mixed

mixed

PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results

**media[466205]**

PDSB MRKD.BA MRK.SN MRK.PA MRK.MX MRK ALPMY ALPMF 6MK.DE 4503N.MX

Read more →
Published at

Oct 22, 2024 6:00 PM

by zacks.com

positive

positive

PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know

PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PDSB

Read more →
Published at

Oct 2, 2024 2:00 PM

by globenewswire.com

positive

positive

PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation

100% 36-month overall survival (OS) and progression-free survival (PFS) rates in patients fully treated with Versamune® HPV combined with chemoradiation...

PDSB

Read more →
Published at

Sep 23, 2024 4:39 PM

by seekingalpha.com

neutral

neutral

PDS Biotechnology: Continuing The Holding Pattern (NASDAQ:PDSB)

PDS Biotechnology's HPV-directed immunotherapy is sparking optimism in the biotech industry. Click here to find out why I am tentatively a buy on PDSB stock.

PDSB

Read more →
Published at

Aug 5, 2024 7:12 PM

by investing.com

mixed

mixed

PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024 By Investing.com

PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024

PDSB SHCAF MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE

Read more →
Published at

Jun 24, 2024 10:56 PM

by investing.com

mixed

mixed

Arvinas appoints new CFO with extensive biopharma experience By Investing.com

Arvinas appoints new CFO with extensive biopharma experience

PFG PDSB ARVN PFE ICPT VYNE

Read more →
Published at

Jun 24, 2024 10:37 PM

by globenewswire.com

mixed

mixed

Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer

- Awards Mr. Saik an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - NEW HAVEN, Conn., June 24, 2024 (GLOBE NEWSWIRE) -- Arvinas,...

ARVN VYNE PDSB ICPT.MX ICPT

Read more →
Published at

Dec 28, 2022 5:30 PM

by marketscreener.com

mixed

mixed

NetScientific says PDS0101 shows median overall survival of 21 months

NetScientific PLC on Wednesday said its portfolio company PDS Biotechnology Corporation had reported a median overall survival of 21 months in its phase 2 clinical trial of PDS0101 triple... | December 28, 2022

NSCI.L PDSB

Read more →
Published at

May 18, 2022 2:10 PM

by news.google.com

neutral

neutral

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development - read this article along with other careers information, tips and advice on BioSpace

XERS SBBP PDSB

Read more →
Published at

May 18, 2022 2:00 PM

by globenewswire.com

neutral

neutral

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)...

XERS SBBP PDSB

Read more →
Published at

May 18, 2022 2:00 PM

by benzinga.com

neutral

neutral

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and

XERS SBBP PDSB

Read more →
Published at

Feb 11, 2021 1:26 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...

VNDA VM4.SG VM4.F TXMD TVTX S1K2.MU S1K2.F S1K2.BE PULM POAI PLX.TA PLX PBDA.MU PBDA.F PBDA.BE O2T.F O2T.BE MRK.PA MRK.MX LYRA KLDO ISEE ILU.SG ILU.MU ILU.F ILU.DE ILU.BE ILMN.MX IDYA GTHX GMDA GKOS GHSI GENE G1H.F G1H.BE EYEN EVGN.TA EVGN EDAP EDA.F EDA.BE DMTK CPTA.F CPTA.BE COLL CLSD CLM.SG CLM.MU CLM.F CLM.BE CLGN BX2.MU BX2.F BX2.BE BTAI BMY 6MK.MU 6MK.F 6MK.DE 6MK.BE 6GJ.F 354.F 30J.MU 30J.F 30J.BE 2PU1.MU 2PU1.F 2PU1.BE 29T.F 29T.BE XNCR XE9.SG XE9.MU XE9.F XE9.BE WEK.SG WEK.MU WEK.F WEK.BE VRCA VCYT US87166B1026.SG UP0.SG UP0.F UG2.SG UG2.F UG2.BE TXG SYNH SYBX SUPN SU6.F SU6.BE SRDX SLRX SLDB SESN SEEL SANA S49.F REGN RARE PSTV PRLD PPBT.TA PPBT PLXP PHVS PDSB PCBK.MU PCBK.F PCBK.BE PACB P09.SG P09.F P09.BE OTIC OPNT ONTX O7PA.MU O7PA.F NXEN.SG NXEN.F NXEN.BE NVCR NMTR NK NG9.MU NG9.F NG9.BE NETWORK.BO NEO.MX NEO NBSE NARI MP6N.F MINA.MU MINA.F MINA.BE MACK LPTX LHDX LGND LGDN.F LGDN.BE KTRA KOD.MX KOD K27.MU K27.F K27.BE ITOS INFI ILMN HDP1.MU HDP1.F HDP1.BE FP11.F FAD2.F FAD2.BE EU6.F DMPWW CGIX BOV.F BIO-B BGNE AYTUZ AYTUW AYTU AVRO AVNS ATRC ASZ1.F ASZ1.BE ASLN ARWR ARTL APYX APLT ANGO ANCN AMTI ALLK ALKS ALIM AGTC AGIO ADXS ACST.V ACST ABT.SW ABT.MX ABT ABL.F ABL.DE A5I.F A1PA.F A1PA.BE 8IN.MU 8IN.F 8HH.MU 8HH.F 8HH.BE 8AP.MU 8AP.F 7OT.MU 7OT.F 7A9.MU 7A9.F 7A9.BE 6160.HK 5MC1.F 49BA.SG 3DM.F 3DM.BE 37Z.SG 37Z.MU 37Z.F 37Z.BE 2UV.MU 2UV.BE 2Q3.F 2Q3.BE 2GT.MU 2GT.F 2GT.BE 1NE.MU 1NE.F 1KJ.MU 1KJ.F 1KJ.BE 1D5A.F 1D5A.BE 12V.F 12V.BE 0T22.SG 0T22.MU 0T22.F 0T22.BE 038.MU 038.F 038.DU ZYNE ZIOP VERU SGT.MU SGT.F SGT.BE SGEN PRTA MYOV MRK KPTI I3F.MU I3F.F I3F.BE GXEA.F GXEA.BE GNCA GLPG GBI1.MU GBI1.F GBI1.BE FMW.MU FMW.F FMW.BE FLDM FLB.MU FLB.F FLB.BE EJU.MU EJU.F EJU.BE DUL.MU DUL.F DUL.DE CLVS CLPT CELC CCCC CBMG CARA C6O.MU C6O.F C6O.DE C6O.BE BOLT ALNY AEMD 71M.SG 71M.F 71M.BE 6ZY.SG 6ZY.MU 6ZY.F 6ZY.BE 69C.MU 69C.F 69C.BE 25K.SG 25K.MU 25K.F 25K.BE 0PT.F

Read more →
Published at

Feb 10, 2021 1:34 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...

XUPB.MU XUPB.F XUPB.BE XUP.MU XUP.F XUP.BE SQZ SAVA RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN PX91.MU PX91.F PX91.BE PLX.TA PLX PBDA.MU PBDA.F PBDA.BE NARI LGND LGDN.F LGDN.BE KTRA KRTX KALV JAZZN.MX JAZZ J7Z.SG J7Z.MU J7Z.F J7Z.BE ITRM ITOS ITCI ILMN GNFTF GNFT.PA GNFT GMDA ENLV.TA ENLV DMPWW CDAK 4XC1.SG 4XC1.F 4XC1.BE 3DM.F 3DM.BE 32W.MU 32W.F 23I.MU 23I.F 23I.BE 1BT.F 1BT.BE VNDA VM4.SG VM4.F UG2.SG UG2.F UG2.BE TXMD TEVAN.MX TEVA TEV.F TERN SYBX SWTX SU6.F SU6.BE SRDX SLRX SESN SEEL RV7.MU RV7.F RV7.BE RGLS RDUS RCUS QIA.SG QIA.MU QIA.F QIA.DE QIA.BE QGEN PYPD PRTK PRTA PRLD PDSB PCBK.MU PCBK.F PCBK.BE PACB P09.SG P09.F P09.BE OTLK OPNT O7PA.MU O7PA.F NXEN.SG NXEN.F NXEN.BE NVV1.MU NVV1.F NVV1.BE NVCR NVAX.MX NVAX NOVN NMTR NK NBSE N4CN.SG N4CN.F N4CN.BE MREO MORF MINA.MU MINA.F MINA.BE MDXG MAH0.SG MAH0.MU MAH0.F MAH0.BE KMDA.TA KMDA INSP ILU.SG ILU.MU ILU.F ILU.DE ILU.BE ILMN.MX IDYA HAZ.MU HAZ.F HALO HAE GKOS GHSI FP11.F FLGT.MX FLGT FLDM FLB.MU FLB.F FLB.BE EYEN EXEL EX9.MU EX9.F EX9.DE EX9.BE EVGN.TA EVGN EU6.F ETON EJU.MU EJU.F EJU.BE EDAP EDA.F EDA.BE DRIO CXF.MU CXF.F CXF.BE COLL CMRX CLPT CELC CCXI CBMG BBIO ASLN ARGX.BR ARGX APVO AP8N.MU AP8N.F ANGO AMRX AGIO AEMD ABCL 8QQ.HM 8AP.MU 8AP.F 7RG1.F 7F0.F 7F0.BE 7A9.MU 7A9.F 7A9.BE 6LU.F 6LU.BE 6GJ.F 41ON.SG 41ON.MU 41ON.F 41ON.BE 354.F 31Y.MU 31Y.F 30J.MU 30J.F 30J.BE 2Q3.F 2Q3.BE 2DR.MU 2DR.F 2DR.BE 2CX.SG 2CX.MU 2CX.BE 2CL.MU 2CL.F 29T.F 29T.BE 1R8.SG 1R8.F 1R8.BE 1AEA.MU 1AE.SG 1AE.MU 1AE.F 1AE.BE 0PT.F 038.MU 038.F 038.DU ZSAN XNCR XE9.SG XE9.MU XE9.F XE9.BE VRCA VERU VCYT VCEL LLY.SG LLY.F LLY.DE LLY.BA LLY FMW.MU FMW.F FMW.BE ATQP.SG ATQP.MU ATQP.F ATQP.BE 1NE.MU 1NE.F 12V.F 12V.BE 0ZPN.SG 0ZPN.F 0ZPN.BE

Read more →
Published at

Feb 10, 2021 8:53 AM

by rttnews.com

mixed

mixed

GMDA On Track, GNFT Soars, HTBX Sparkles, LLY's Neutralizing Antibody Therapies Get FDA Nod

Today's Daily Dose brings you news about KalVista's hereditary angioedema trial results, Heat Biologics' encouraging data from its phase II trial of HS-110 in non-small cell lung cancer, Gamida's presentation of full efficacy and safety results of Omidubicel in patients with hematologic malignancies and Neovasc regaining Nasdaq compliance.

NVCN.TO NVCN HTBX GMDA G5Z3.MU G5Z3.F G5Z3.BE 4XC1.SG 4XC1.F 4XC1.BE VERU PDSB KALV ITRM FMW.MU FMW.F FMW.BE ET82.SG ET82.MU ET82.F ET82.DU ET82.BE BO1.MU BO1.F BO1.BE BCRX AEZS.TO AEZS LLY.SG LLY.F LLY.DE LLY.BA LLY

Read more →